(1)
Mallmann, Q. The Tension Between “Brand-Name” Drugs And “Generics”: The Pharmaceutical Industry’s Temporary Monopoly And The Public Domain – The Legal Regime For Invention Patents. PIDCC 2026, 15 (1), e20261501005. https://doi.org/10.16928/e20261501005.